ArticleJournal of cardiovascular development and disease2026
Paradoxical Trends in Hypertensive Heart Disease: Rising Burden in High-Sociodemographic-Index Regions Despite Healthcare Quality-An Age-Period-Cohort Analysis, 1992-2021.
Article in Journal of cardiovascular development and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertensive heart disease (HHD) is a major global cause of cardiovascular mortality and disability-adjusted life years (DALYs). We used an age-period-cohort model to assess mortality and DALY trends (1992-2021) across sociodemographic regions and their association with healthcare quality. Using Global Burden of Disease (GBD) data (1992-2021), we applied an age-period-cohort model to HHD mortality and DALYs in adults aged 20-54 across SDI regions and examined associations with healthcare quality. HHD mortality and DALYs declined across most SDI regions over 29 years, with high-middle SDI females showing the greatest reductions (ASMR: -3.2% annually; ASDR: -2.9%). Conversely, high-SDI regions exhibited rises of ~1.7% and ~1.2% in males and females, respectively. Low-SDI regions maintained the highest absolute burden, with 2021 mortality rates 10-fold higher in males and 13.7-fold higher in females versus high-SDI regions, despite the steepest declines. The male-to-female mortality ratio ranged from 1.74× (high-middle SDI) to 1.14× (low SDI). Age-related patterns diverged markedly: high-SDI females showed a 46.7% risk decline for ages 20-54, while males experienced a 92-111% lifespan risk increase. Period effects showed pre-2002 peak risk in lower-SDI versus post-2002 increases in high-SDI regions (males: +36%; females: +24%). The 1997-2001 birth cohort in high-SDI regions showed the highest risk (males: RR 1.75-1.85; females: RR 1.45-1.50). No significant correlation was found between HHD burden and HAQI (ASMR: r = 0.40; ASDR: r = 0.42;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.